Skickas . Fri frakt för medlemmar vid köp för minst 249 kr.
Biological differences between the sexes influence not only individual health but also public health, biomedical research, and health care. The Institute of Medicine held a workshop March 8-9, 2010, to discuss sex differences and their implications for translational neuroscience research, which bridges the gap between scientific discovery and application.
1 Front Matter; 2 1 Introduction; 3 2 Studying Sex Differences in Health and Disease; 4 3 Studying Sex Differences in Translational Research: Examples from Four Major Disease Areas; 5 4 Reporting Sex Differences in Research Publications; 6 5 Sex Differences in Drug Development: Policy and Practice; 7 6 Needs, Opportunities, and Next Steps; 8 Appendix A: References; 9 Appendix B: Registered Attendees; 10 Appendix C: Workshop Agenda
National Research Council, Division of Behavioral and Social Sciences and Education, Institute of Medicine, and Families Board on Children, Youth, Steve Olson
Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health
Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Joseph Lipscomb
Institute of Medicine, Board on Health Sciences Policy, African Science Academy Development Initiative, Forum on Neuroscience and Nervous System Disorders, Bruce M. Altevogt, Patricia A. Cuff, Theresa M. Wizemann, Diana E. Pankevich
National Research Council, Division on Earth and Life Studies, Board on Life Sciences, Institute of Medicine, Board on Health Sciences Policy, Committee on the Use of Chimpanzees in Biomedical and Behavioral Research, Jeffrey P. Kahn, Marilee K. Shelton-Davenport, Diana E. Pankevich, Bruce M. Altevogt
National Research Council, Institute of Medicine, Division on Earth and Life Studies, Institute for Laboratory Animal Research, Policy and Global Affairs, and Law Committee on Science, Technology, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Bruce M. Altevogt, Anne-Marie Mazza, Theresa M. Wizemann, Diana E. Pankevich
Institute of Medicine, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Bruce M. Altevogt, Diana E. Pankevich, Theresa Wizemann
Institute of Medicine, Board on Health Sciences Policy, Forum on Neuroscience and Nervous Systems Disorders, Bruce M. Altevogt, Theresa Wizemann, Diana E. Pankevich
Institute of Medicine, Board on Health Sciences Policy, Forum on Medical and Public Health Preparedness for Catastrophic Events, and Translation Forum on Drug Discovery, Development, Anne B. Claiborne, Bruce M. Altevogt, Theresa Wizemann
Institute of Medicine, Board on Global Health, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Bruce M. Altevogt, Theresa M. Wizemann, Sheena M. Posey Norris, Diane E. Pankevich
Institute of Medicine, Board on Health Sciences Policy, Forum on Medical and Public Health Preparedness for Catastrophic Events, Theresa Wizemann, Clare Stroud, Bruce M. Altevogt
Institute of Medicine, Board on Health Sciences Policy, Forum on Medical and Public Health Preparedness for Catastrophic Events, Bruce M. Altevogt, Theresa Wizemann, Kristin Viswanathan
Institute of Medicine, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Forum on Medical and Public Health Preparedness for Catastrophic Events, Bruce M. Altevogt, Clare Stroud, Theresa Wizemann